2Watkins PJ. clinica la observations and experiments in diabetic neuroppathy diabetologia 1992; 35:2. 被引量：1
3Peterson HM, Fromby B. Glycosylated proteins ln: Alberti KGMM, krall Lp. eds, The diabetes annual2, Amsterdan Elserier1986; 137. 被引量：1
4T. A. Chowdhury,P. H. Dyer,C. H. Mijovic,D. B. Dunger,A. H. Barnett,S. C. Bain. Human leucocyte antigen and insulin gene regions and nephropathy in Type I diabetes[J] 1999,Diabetologia(8):1017～1020 被引量：1
5. A common mutation of the methylenetetrahydrofolate reductase gene as a risk factor for diabetic nephropathy[J] 1999,Diabetologia(5):631～632 被引量：1
6. Is Trp64Arg polymorphism of β3-adrenergic receptor a clinically useful marker for the predisposition to diabetic nephropathy in Type II diabetic patients?[J] 1999,Diabetologia(5):632～633 被引量：1
7D. G. Fogarty,M. J. Zychma,L. J. Scott,J. H. Warram,A. S. Krolewski. The C825T polymorphism in the human G-protein β3 subunit gene is not associated with diabetic nephropathy in Type I diabetes mellitus[J] 1998,Diabetologia(11):1304～1308 被引量：1
8T. Fujisawa,H. Ikegami,Y. Kawaguchi,Y. Hamada,H. Ueda,M. Shintani,M. Fukuda,T. Ogihara. Meta-analysis of association of insertion/deletion polymorphism of angiotensin I-converting enzyme gene with diabetic nephropathy and retinopathy[J] 1998,Diabetologia(1):47～53 被引量：1
9Lgnarro LJ,Buga GM,Wood KS,et al.Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide[].Proceedings of the National Academy of Sciences of the United States of America.1997 被引量：1
10Benigni A,Colsiol V,Brena C,et al.Unselective inhibition of endothelin receptors reduces renal dysfunction in experimental diabetes[].Diabetes.1998 被引量：1
2Mogensen CE.Management of early nephropathy in diabetic patients[J].Annu Rev Med,1995,(46):79. 被引量：1
3Wolf G.Cell cycle regulation in diabetic nephropathy[J].Kinney Int,2000,58(Suppl77):59. 被引量：1
4Chen S,Evans T,Deng D,et al.Hyperhexosemia induced functional and strutural changes in the kidneys:role of endothelins[J].Nephron,2002,90(1):86 -94. 被引量：1
